Kaken Pharmaceutical will hand Alumis $40 million in the near term for the rights to develop a late-stage tyrosine kinase 2 ...
iStock’s ever-growing Signature collection features millions of authentic images—including these awe-inspiring Tattoo illustrations—that you won’t find on any other stock site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback